News | January 07, 2008

Young, Obese Women with PCOS at Risk for Coronary Atherosclerosis

January 8, 2008 – Young, obese women with polycystic ovary syndrome (PCOS) may be at increased risk for early subclinical coronary atherosclerosis, independent of the presence of traditional cardiovascular risk factors and novel inflammatory risk markers, according to a study by researchers at the University of Iowa published in the December issue of the Journal of Clinical Endocrinology and Metabolism.

The study involved 24 women, between 21 and 50 years of age, with PCOS and a body mass index of 30 or higher, and 24 weight- and age-matched controls without PCOS. Eight of 24 PCOS subjects, or 33 percent, and two of 24 controls, or 8 percent, were diagnosed with coronary artery calcium, an indicator of early-onset atherosclerosis.

Additionally, researchers found that the majority of women with detectable coronary artery calcium did not have traditional cardiovascular risk factors “and the presence of PCOS status per se appeared to contribute to this increased risk of coronary artery calcium,” said Rupal Shroff, M.D., one of the researchers at University of Iowa.

For more information: jcem.endojournals.org


Related Content

News | Cardiovascular Clinical Studies

Jan. 13, — A new cohort study among 103,642 adults found that current use of cigars was associated with increased risk ...

Home January 14, 2025
Home
News | Cardiovascular Clinical Studies

Nov. 22, 2024 — BridgeBio Pharma, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved ...

Home November 25, 2024
Home
News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
Subscribe Now